THERAPEUTIC AGENT ANTIBODY TARGETED TREATMENT

Brand Owner (click to sort) Address Description
CEA-CIDE IMMUNOMEDICS, INC. 300 American Road Morris Plains NJ 07950 therapeutic agent for antibody-targeted treatment of colorectal cancer and other cancers associated with CEA antigen;SEA SIDE;
LYMPHOCIDE IMMUNOMEDICS, INC. 300 American Road Morris Plains NJ 07950 therapeutic agent for antibody-targeted treatment of lymphoma;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Methods and compositions are disclosed that are useful for the prevention and/or treatment of cancer, angiogenesis, and inflammation. The beneficial effects of the compositions and methods are achieved through the use of pharmaceutical compositions that include agents that bind spingolipids or sphingolipid metabolites. In one embodiment the agent is an antibody or antibody derivative. In some embodiments, the agent is a receptor of a sphingolipid or a sphingolipid metabolite. Also disclosed are methods for identifying and isolating therapeutic agents.